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Radionuclide examinations provide considerable information in evaluating patients who have received renal transplants. In the uncomplicated case, baseline data should be
obtained so that subsequent changes in renal function can
be better documented. In the complicated case, rapid
delineation of the problem may result in more effective
therapy. Serial examinations with several radiopharmaceuticals represent the best nuclear approach to the transplant
patient. This paper describes the application and performance of these tests as currently performed at Henry Ford
Hospital.

rOSTOPERATIVELY, many complications face the renal
transplant patient. Some, such as rejection and acute tubular
necrosis, may be expected but not predicted as to onset or
severity. Others, which may be secondary to surgery itself,
include the hematomas, urinomas, obstructions, and lymphocoeles. Whatever the potential problems, radionuclide
evaluation can play an important role, eitherto elucidate the
complication, or as a complement to other examinations.
While other procedures such as arteriography may provide
more precise anatomic information, the noninvasive nature
of a nuclear examination is advantageous for the patient.
Ultrasound is also noninvasive but cannot provide functional data about the transplant. All three modalities, therefore, have their uses in the evaluation and management of
the transplant patient. When renal failure occurs, excretory
urography is of minimal value and its routine use should be
discontinued.
This paper will concern Itself with radionuclide methods
that can be applied to renal transplants. Ideally, one would
hope to clearly separate the various complications from
each other, particularly acute tubular necrosis (ATN) and
rejection. Practically, however, we are looking only at
manifestations of renal blood flow and tubular function,
which when correlated with the chronology of the clinical
setting, allow us to make reasonable assumptions about the
transplant. Moreover, complications may be multiple, occurring either sequentially or concurrently

Methods
Two radionuclides linked to three radiopharmaceuticals
(Tc-99m sulfur colloid, Tc-99m DTPA, and 1-131 orthoiodohippuric acid) are used in the routine examination of
the transplant patient. Tc-99m is an ideal radionuclide
because of its photon energy (140 KeV), which allows for
efficient detection, lack of any beta (electron) radiations,
and a short half-life of six hours, lodine-131 suffers from poor
imaging energy (364 KeV), significant beta radiations, and
an eight-day half-life. For these reasons, 1-131 mustbe used
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in microcurie doses, although it remains the only widely
available radionuclide which can be chemically linked to
ortho-hippuric acid. Hopefully, progress with 1-123 (almost
as ideal an isotope as Tc-99m) will soon provide us with
1-123 hippuric acid.

Tc-99m sulfur colloid
In 1974, Solaric-George, et a l ' first described radiocolloid
uptake in renal transplants. Their findings suggested a high
degree of correlation in differentiating chronic rejection
from other causes of transplant dysfunction. Those patients
with chronic rejection showed marked uptake, whereas
those with ATN and acute rejection showed little or no
uptake.^'*'^ In using sulfurcolloid to image the liver, spleen,
or bone marrow, one depends onthe ability of macrophages
to trap the colloidal particle. This mechanism is not respon-

When a request for examination of a transplant patient is
received, it is handled as an urgent case, especially in the
immediate postoperative period. The first examination
should be performed within 24 to 72 hours after implantation. Serial examinations to document improvement or
deterioration in renal function are much better than a single
examination^ and are obtained as frequently as the clinical
situation dictates. Typically, two or three examinations may
be performed at weekly intervals until renal dynamics
become stabilized. Except where individualized to fit the
particular case, all patients are routinely given the three
radiopharmaceuticals in the sequence described below.

Fig. 2
Tc-99m DTPA
Imagesobtained from the gamma camera just after IV injection. Note well
visualized lower abdominal aorta, transplant, iliac, and femoral vessels.

Fig.1
Tc-99m S u l f u r c o l l o i d
Anterior view over pelvis. Note moderate uptake in transplant (top). Two
weeks later marked uptake is seen during a rejection episode (bottom).

Fig. 3
Computer image from Tc-99m DTPA flow study showing placement of
regions-of-interest over distal aorta (small arrow) and transplant (large
arrow).
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Fig. 4
Computer printout showing determination of aorto-renal transit time by
finding the separation between peak arrival time in each area (X =
Transplant • = Aorta).

sible for transplant visualization. Rather, it seems that the
particles "stick" to intravascular fibrin deposits which form
during rejection. However, Frick, et al^ found that while
89% of rejecting transplants showed activity, 30% of those
with acute tubular necrosis and 30% of those with sepsis
also showed significant activity. In their view, these findings
diminish the specificity of colloid uptake as a means of
differentiation. It must also be remembered that, for unknown reasons, patients with both right- and left-sided
congestive heart failure may show renal radiocolloid uptake.^ The frequent coexistence of ATN and rejection also
cloudsthe issue. We hope to evaluate our results with sulfur
colloid in a future report. A case demonstrating progression
from minimal to marked uptake is shown in Figure 1.

Fig. 5
Nonperfused and nonfunctioning transplant.
Note absence of any activity w i t h O I H (A),
Tc-99m DTPA (B), or Tc-99m sulfur colloid (C). .

A dose of 5 mCi is administered and the patient imaged
10-20 minutes later. Since most activity is accumulated by
liver and spleen, care mustbe taken to excl ude these organs
from the field of view, or the bone marrow and transplant
will not be visualized for technical reasons. In our experience, most transplants have shown at least some activity. If
no activity is seen in the transplant (Figure 5C), one must
consider the possibility of vascular occlusion.
Tc-99m DTPA

via a reducing agent (tin), DTPA is handled in the kidney by
glomerular filtration, although only a relatively small fraction is filtered during each circulation through the kidney.
The tubules do not play any significant secretory or resorptive role in DTPA excretion. Thus, because there is some
renal concentration of DTPA and because of the high photon
fl ux of Tc-99m, we have an excel lent com pound for eval uating renal perfusion.

DTPA is the chemical compound diethylenetriaminepentacetic acid, which is a chelating agent. Coupled to Tc-99m

Ten to 15 mCi are injected through an antecubital vein as a
bolus, while the patient lies beneath the gamma camera
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Fig. 7
Normal transplant renogram curve w i t h 1-131 O I H . Note rapid accumulation phase leading to a peak at 4 minutes (X = Transplant • = Bladder).

detector head. An image of the transplant and major vessels
isobtained (Figure 2) which allows transplant size and gross
morphology to be evaluated. Segmental perfusion abnormal ities may also be revealed." At the same time, information is fed to the computer, which formulates the data into
two-second intervals for two minutes. The computer operator will then form a cumulative image from regions-ofinterest located over the transplant and distal aorta (Figure
3). The computer is thus able to print out time-activity curves

Fig. 6
Postoperative Hematoma
A. Tc-99m DTPA shows perfused transplant (large arrow). An area of
slightly decreased (compared to background) activity can be faintly seen
in the pelvis (small arrows).
B. 30-minute delay DTPA image. Activity now seen in renal pelvis (large
arrow) and bladder (small arrow) which is displaced by the hematoma.
C. Postoperative delayed DTPA image shows thaf bladder has returned to
midline following removal of the hematoma.
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Fig. 8
Computer images (1-131 O I H renogram) demonstrating normal cortical accumulation
(A) w i t h rapid progression of activity into collecting system
and bladder (B - E).

over each region, which are graphic representations of bolus
arrival, peak activity, and equilibration in the aorta and
transplant

A DTPA image is also obtained after a delay of 30 minutes
(post injection). Using this image and those from the early
flow study, one can eval uate for space-occupyingcompi ications, such as urinoma or hematoma (Figure 6), in addition
to looking for possible urinary tract obstruction. In our
experience, such problems have been rare, but their presence (or absence) has great importance for patient care.

Thetime between peak activity in aorta and in the transplant
is the aorto-renal transit time (Figure 4). It provides a more
objective measurement of perfusion and is another tool to
help differentiate between ATN and rejection.' Normal
values are between two to eight seconds. Generally, rejection causes a greater delay in transit time than does ATN,
probably because of edema and intravascular fibrin deposition in the transplant. Most cases of ATN are a result of the
varying periods of anoxia suffered by cadaver transplants in
the donor during harvesting, rather than acute vascular
compromise in the recipient. More sophisticated measurements, such as the transplant perfusion index^° and
kidney/aortic blood flow index (K/A ratio)," have also
been described, but their ability to differentiate between
ATN and rejection may be no better than the transit time.
Complete lack of perfusion (Figure 5B), or marked delay, is
an indication for additional study, sinceone cannot differentiate between the various possible vascular abnormalities
with radionuclides. Major occlusions of the renal artery or
vein and diffuse intrarenal vascular problems require angiographic diagnosis.

1-131 ortho-lodohippuric acid
Ortho-iodohippuricacid (OIH) is a derivative of para-am ino
hippuric acid (PAH). Both share important physiologic
properties, and functional parameters are reflected by the
way in which the kidney handles these compounds.
Their first important property is that, in small doses, 90% of
the PAH (or OIH) concentration in renal arterial blood is
removed in a single circulation,'^ which, forclinical purposes, can be considered a total extraction. When this
compound is given as a radioactive bolus, it is thus possible
to evaluate renal function as reflected in a single pass
phenomenon seen by an external detector. Secondly, since
P A H / O I H is handled both by glomerular filtration (20%)
and by tubular secretion (80%),^ it is also possible to view
the two basic renal functional compartments during that
single circulation. Finally, there is no tubular reabsorption.
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excretion, as the isotope moves down the distal tubules to
the collecting system, removing itself from view, until it
reappears in the bladder. Naturally all phases ofthe curve
are interrelated, and abnormality in any one portion may
produce an abnormality elsewhere in the curve. For example, a vascular problem will cause delay in delivery of
isotope, with subsequent delay in tubular accumulation.
Both factors will lead to a delay in appearance-time of the
peak and some prolongation of the excretory phase. Relative count-rates over the transplant (compared to background) are generally lower when vascular complications
are present. Intra- or extrarenal urinary obstruction also
causes a delay in peak time secondary to prolonged and
c o n t i n u e d a c c u m u l a t i o n due to non removal. Relative
count-rates will thus be higher than normal, presuming that
renal function has not been significantly reduced. The point
to emphasize is that the shape and relative height of the
time-activity curves represent effective renal plasma flow,
glomerular filtration ratio, proximal tubular function, and
tubular urine flow.
In addition to the curves, the computer will reconstruct
images that visually interpret the same information used to
generate the curves. The 20-minute period of observation
will be reconstructed as 20 sequentially-displayed, oneminute images, from which one expects to see normal
progression of the radioisotope through the transplant (Figure 8). This consists of initial appearance of activity in the
cortical region, movement into the medul la (causing apparent decrease in renal size), and finally, visualization of the
renal pelvis and bladder. In ATN there is obstruction to urine
flowwithin distal tubulesand collecting ducts probably due
to cellular debris. Figure 9 shows prolonged intraparenchymal retention ofactivity. The proximal tubular cells are more
resistantto anoxic damage^ and their function is relatively
preserved. Delivery and accumulation of activity are maintained, unless ATN is secondary to acute vascular obstruction. When rejection predominates, parenchymal retention
is also seen but is usually less severe than ATN.

Fig. 9
A. Computer images ( i - 1 3 1 0 IH) at 17-20 minutes demonstrating delayed
retention of activity in renal parenchyma during episode of ATN. No
activity seen in collecting system.
B. Two weeks later: 1-131 O I H computer images at 17-20 minutes now
show activity in renal pelvis and bladder indicating resolution.

and PAH/OIH secretion occurs by active transport, which
occurs mostly in proximal tubular c e l l s . T h i s last fact has
important implications for renal transplants, as will be
described later.

One last note: Patients receiving 1-131 OIH should be given
a blocking dose of Lugol's solution to reduce radioiodine
uptake bythe thyroid, and subsequentdaily doses should be
continued for one to two weeks.

With the patient lying beneath the camera detector, a 400
mCi (0.4 mCi) bolus of 1-131 OIH is injected through an
antecubital vein. No images are made during this time, but
forthe next 20 minutes data are being sent to the computer
from which a time-activity curve over both the transplant
and bladder will be generated (Figure 7). The renal curve has
three phases. The first reflects delivery of isotope to the
kidney and its accumulation by the proximal tubular cells.
The rate-of-rise of the accumulative phase is a rough
estimate of the function of those cells. The second phase,
called the peak, representsa very short equilibrium between
accumulation and excretion and normally will occur between three to five minutes. The third phase represents

Conclusion
Radionuclides provide a rapid, noninvasive method for
evaluating renal transplant patients. Both functional and
anatomic information is readily obtained. While the exact
differentiation between ATN and rejection remains an elusive goal, the use of multiple radionuclides and serial
examinations has made significant inroads towards solving
this problem. The accompanying table summarizes the
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DIFFERENTIATION OF ATN AND REJECTION USING THREE RADIOPHARMACEUTICALS
RADIONUCLIDE

NORMAL

Tc-99m

ACTIVITY =

SULFUR COLLOID

NONE - MINIMAL

NONE - MODERATE

MODERATE - MARKED

AORTO - RENAL

MILD - MODERATE
PROLONGATION,

MODERATE - MARKED
PROLONGATION,

ATN

REJECTION

ACTIVITY =

Tc-99iii

ACTIVITY =

TRANSIT TIME = 2 - 8 SEC.
DTPA
(FLOW STUDY)

TRANSIT TIME = 8 - 1 2 SEC.

TRANSIT TIME =
10 - 16 SEC.

NO ACTIVITY IN TRANSPLANT - VASCULAR OCCLUSION

1-131
OIH

RAPID ACCUMULATION,

RAPID - FAIR
ACCUMULATION,

NORMAL RADIONUCLIDE
PROGRESSION

MARKED PARENCHYMAL
RETENTION

findings in both ATN and rejection, but it should be emphasized that these cannot always be easily categorized, and the
table provides only a guideline.

POOR ACCUMULATION,
MILD PARENCYMAL
RETENTION

must rely on counting statistics alone. Further development
of 1-123" is eagerly awaited, as this will allow for a single
study capable of p r o v i d i n g f u n c t i o n a l and anatomic
information.

Some authors''^ have also reported on the use of 1-125
fibrinogen and Ga-67 in renal transplants. Each of these
radionuclides can accumulate in the transplant during
rejection. Unfortunately, in the postoperative period (often
the most crucial), they may accumulate secondary to the
operation itself. In addition, because 1-125 also has a photon
energy (27 KeV) that is too low to be imaged effectively, one

Acknowledgments
I would like to thank Kamilia F. Gitschlag, M.D., Ronald S.
Petrocelli, M.D., and Mark F. Pezda, M.D. for their professional criticism and helpful suggestions in writingthis paper.

25

Marks

References

7. Higgins CB, Taketa RM, Taylor A, et a l : Renal uptake of Tc-99m sulfur
colloid, I N u d Med 15:564-566, 1974,

1. zum Winkel K, Harbst H, Das KB, and Newiger T: Applications of
radionuclides in renal transplantation. Semin N u d Med 4:169-186,
1974.

8. Shimshak RR, Hattner RS, Tucker C, and Salvatierra O : Segmental
acute tubular necrosis in kidneys with multiple renal arteries transplanted from living donors. / N u d Med 18:1074-1078, 1977.

2. Solaric-George EA, Fletcher JW, Newton WT, et a/: Renal accumulat i o n of T c - 9 9 m sulfur col loid in transplant r e j e c t i o n . R a d i o l o g y
111:465-466, 1974.

9. Delmonico FL, McKusick KA, Cosimi AB, and Russel PS: Differentiation between renal allograft rejection and acute tubular necrosis by
renal scan. A m / Roentgenol 128:625-628, 1977.

3. George EA, Codd JE, Newton WT, et at: Comparative evaluation of
renal transplant rejection with radioiodinated fibrinogen, Tc-99m
sulfurcolloid, and Ga-67 citrate./ Nuc/ Med 17:175-180, 1976.

10. Hilson AJW, Maisey M N , Ogg CS, et at: Quantitative assessment of
renal transplants with Tc-99m DTPA: Experience with 955 cases.y Nuc/
Med 18:595, 1977,

4. George EA, Codd JE, Newton WT,et a/: Further evaluation of Tc-99m
sulfurcolloid accumulation in rejecting renal transplants in man and a
canine model. Radiology 116:121-126, 1975.

11. Kirchner PT, Goldman M, Leapman S, and Kiepfer RF: Accuracy of the
kidney/aortic blood flow index ( K / A ratio) for assessing renal transplant function, I N u d Med 18:595-596, 1977.

5. Kim YC, Massari PLI, Brown ML, et a l : Clinical significance of Tc-99m
sulfur colloid accumulation in renal transplant patients. Radiology
124:745-748, 1977.

12. Ganong WF: /Review of Medical Physiology. Los Altos, Calif, Lange
Medical Publishers, 1963, pp 524, 530,
13. Zielinski FW, Holly FE, Robinson G D , e t a / : Total and individual kidney
function assessment with lodine-123 ortho-iodohippurate. Radiology
125:753-759, 1977.

6. Frick MP, Loken MK, Goldberg ME, and Simmons RL: Use of Tc-99m
sulfurcolloid in evaluation of renal transplant complications. / N u d
Med 17:181-183, 1976,

26

